 But in the absence of a vaccine, the virus does continue to spread to new victims. There are still around a million new cases each year. The good news is the early conclusion of a trial of a preventive treatment called lenacapavir, reporting early because the statistics from the trial showed it was so good at protecting young women from infection. The approach is what they call PrEP –